5N Plus Inc. (TSX:VNP)

Sage Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,375	657	335	257	210	241
Market Cap Growth	43.05%	95.98%	30.45%	22.27%	-12.84%	17.56%
Enterprise Value	1,519	826	481	412	240	282
Last Close Price	15.44	7.38	3.78	2.91	2.38	2.95
PE Ratio	31.44	31.13	16.49	-	53.42	86.60
Forward PE	24.69	22.63	14.31	15.36	17.10	16.94
PS Ratio	3.02	1.58	1.05	0.72	0.79	1.07
PB Ratio	5.86	3.29	1.97	1.68	1.22	1.60
P/TBV Ratio	7.42	4.33	2.90	2.74	2.03	1.74
P/FCF Ratio	102.92	-	155.48	24.73	34.01	6.67
P/OCF Ratio	41.35	-	13.38	8.00	16.18	5.14
EV/Sales Ratio	3.34	1.99	1.50	1.15	0.91	1.25
EV/EBITDA Ratio	15.45	11.47	10.55	11.45	7.25	9.27
EV/EBIT Ratio	20.49	16.11	17.59	26.97	12.51	16.48
EV/FCF Ratio	113.67	-	223.02	39.62	38.89	7.80
Debt / Equity Ratio	0.89	1.09	1.08	1.34	1.09	0.47
Debt / EBITDA Ratio	2.14	2.88	3.74	5.17	5.32	2.21
Debt / FCF Ratio	15.71	-	84.90	19.72	30.45	1.97
Asset Turnover	0.83	0.80	0.69	0.73	0.70	0.78
Inventory Turnover	1.83	1.74	1.92	2.37	2.11	1.87
Quick Ratio	1.39	1.09	0.85	1.29	1.28	2.07
Current Ratio	3.35	3.59	2.22	2.98	3.01	4.13
Return on Equity (ROE)	20.93%	10.96%	12.76%	-18.47%	2.44%	1.85%
Return on Assets (ROA)	8.48%	6.13%	3.71%	1.96%	3.16%	3.68%
Return on Capital (ROIC)	11.12%	7.99%	4.87%	2.57%	4.13%	4.76%
Return on Capital Employed (ROCE)	15.30%	11.30%	7.70%	4.00%	4.90%	7.10%
Earnings Yield	3.19%	3.21%	6.07%	-12.11%	1.87%	1.16%
FCF Yield	0.97%	-6.05%	0.64%	4.04%	2.94%	14.99%
Buyback Yield / Dilution	-0.54%	-0.69%	-0.81%	-6.69%	-0.39%	1.78%

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.